INVO Bioscience News

INVODelisted Stock  USD 0.72  0.02  2.70%   
About 62% of INVO Bioscience's investor base is looking to short. The analysis of current outlook of investing in INVO Bioscience suggests that many traders are alarmed regarding INVO Bioscience's prospects. INVO Bioscience's investing sentiment overview a quick insight into current market opportunities from investing in INVO Bioscience. Many technical investors use INVO Bioscience stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
over a year ago at thelincolnianonline.com         
Reviewing INVO Bioscience NeuroPace
news
over a year ago at www.macroaxis.com         
Sale by Ranoux Claude of 500000 shares of INVO Bioscience
Macroaxis News
over a year ago at benzinga.com         
INVO Bioscience Chief Operating Officer Awarded 28K Worth of Stock Options
benzinga news
over a year ago at www.macroaxis.com         
Acquisition by Ryan Barbara of 85000 shares of INVO Bioscience subject to Rule 16b-3
Macroaxis News
over a year ago at insidermonkey.com         
INVO Bioscience, Inc. Q1 2023 Earnings Call Transcript
insidermonkey News
over a year ago at finance.yahoo.com         
INVO Reports First Quarter 2023 Financial Results
Yahoo News
over a year ago at finance.yahoo.com         
INVO Bioscience to Report First Quarter 2023 Financial Results on Monday, May 15, 2023
Yahoo News
over a year ago at reuters.com         
China weighs giving single women IVF access to stem population decline
reuters
over a year ago at simplywall.st         
INVO Bioscience, Inc. When Will It Breakeven?
Simply Wall St News at Macroaxis
over a year ago at simplywall.st         
INVO Bioscience Full Year 2022 Earnings Revenues Beat Expectations, EPS Lags
Simply Wall St News at Macroaxis
over a year ago at investing.com         
INVO Bioscience earnings missed by 0.04, revenue topped estimates
Investing News at Macroaxis
over a year ago at finance.yahoo.com         
INVO Reports Fourth Quarter and Full Year 2022 Financial Results
Yahoo News
over a year ago at finance.yahoo.com         
INVO Bioscience to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Monday, April 17,...
Yahoo News
over a year ago at finance.yahoo.com         
INVO Congratulates Wisconsin Fertility Institute on Being Named One of Americas Best Fertility Clini...
Yahoo News
over a year ago at news.google.com         
What is the Markets View on Invo Bioscience Inc Stocks Price and Volume Trends Tuesday - InvestorsOb...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about INVO Bioscience that are available to investors today. That information is available publicly through INVO media outlets and privately through word of mouth or via INVO internal channels. However, regardless of the origin, that massive amount of INVO data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of INVO Bioscience news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of INVO Bioscience relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to INVO Bioscience's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive INVO Bioscience alpha.

INVO Bioscience Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
INVO Bioscience and NAYA Biosciences Close Merger,Combined Company to Operate as NAYA Biosciences
10/14/2024
2
INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences
10/21/2024
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Consideration for investing in INVO Stock

If you are still planning to invest in INVO Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the INVO Bioscience's history and understand the potential risks before investing.
Commodity Directory
Find actively traded commodities issued by global exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
CEOs Directory
Screen CEOs from public companies around the world
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk